Literature DB >> 26589262

cAMP effects in neuroendocrine tumors: The role of Epac and PKA in cell proliferation and adhesion.

E Vitali1, V Cambiaghi1, A Spada2, A Tresoldi1, A Zerbi3, E Peverelli2, C Carnaghi4, G Mantovani2, A G Lania5.   

Abstract

cAMP effects have been initially attributed to protein kinase A (PKA) activation. Subsequently, two exchange proteins directly activated by cAMP (Epac1/2) have been identified as cAMP targets. Aim of this study was to investigate cAMP effects in pancreatic-NET (P-NET) and bronchial carcinoids and in corresponding cell lines (QGP-1 and H727) on cell proliferation and adhesion and to determine PKA and Epac role in mediating these effects. We found that cAMP increased cyclin D1 expression in P-NET and QGP-1 cells, whereas it had opposite effects on bronchial carcinoids and H727 cells and it promoted cell adhesion in QGP-1 and H727 cells. These effects are mimicked by Epac and PKA specific analogs, activating the small GTPase Rap1. In conclusion, we demonstrated that cAMP exerted divergent effects on proliferation and promoted cell adhesion of different neuroendocrine cell types, these effects being mediated by both Epac and PKA and involving the same effector GTPase Rap1.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CAMP; CAMP-dependent Protein Kinase A (PKA); Exchange proteins directly activated by cAMP (Epac); Neuroendocrine tumors; Ras-like GTPase Rap1

Mesh:

Substances:

Year:  2015        PMID: 26589262     DOI: 10.1016/j.yexcr.2015.11.011

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

Review 1.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 2.  cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach.

Authors:  Muhammad Bilal Ahmed; Abdullah A A Alghamdi; Salman Ul Islam; Joon-Seok Lee; Young-Sup Lee
Journal:  Cells       Date:  2022-06-24       Impact factor: 7.666

3.  TNF-α impairs EP4 signaling through the association of TRAF2-GRK2 in primary fibroblast-like synoviocytes.

Authors:  Yu Tai; Bei Huang; Pai-Pai Guo; Zhen Wang; Zheng-Wei Zhou; Man-Man Wang; Han-Fei Sun; Yong Hu; Sheng-Lin Xu; Ling-Ling Zhang; Qing-Tong Wang; Wei Wei
Journal:  Acta Pharmacol Sin       Date:  2021-04-15       Impact factor: 6.150

Review 4.  Targeting Cyclic AMP Signalling in Hepatocellular Carcinoma.

Authors:  Mara Massimi; Federica Ragusa; Silvia Cardarelli; Mauro Giorgi
Journal:  Cells       Date:  2019-11-25       Impact factor: 6.600

Review 5.  Ending Restenosis: Inhibition of Vascular Smooth Muscle Cell Proliferation by cAMP.

Authors:  Sarah A Smith; Andrew C Newby; Mark Bond
Journal:  Cells       Date:  2019-11-16       Impact factor: 7.666

Review 6.  The Role of Neuropeptide-Stimulated cAMP-EPACs Signalling in Cancer Cells.

Authors:  Zhengyin Gao; Weng I Lei; Leo Tsz On Lee
Journal:  Molecules       Date:  2022-01-05       Impact factor: 4.411

7.  FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression.

Authors:  Eleonora Vitali; Ilena Boemi; Lorenzo Rosso; Valeria Cambiaghi; Pierluigi Novellis; Giovanna Mantovani; Anna Spada; Marco Alloisio; Giulia Veronesi; Stefano Ferrero; Andrea G Lania
Journal:  Oncotarget       Date:  2017-08-24

Review 8.  The Role of Epac in Cancer Progression.

Authors:  Nadine Wehbe; Hasan Slika; Joelle Mesmar; Suzanne A Nasser; Gianfranco Pintus; Serine Baydoun; Adnan Badran; Firas Kobeissy; Ali H Eid; Elias Baydoun
Journal:  Int J Mol Sci       Date:  2020-09-05       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.